<DOC>
	<DOCNO>NCT01888692</DOCNO>
	<brief_summary>Acknowledging level I evidence already exist regard general beneficial impact FDG PET stag subsequent management lung cancer investigator postulate fuse PET/CT data set RT CT simulation data set adult patient conventionally/clinically assessed stage III non-small cell lung cancer significant impact GTV well normal tissue irradiation . This research also estimate inter intra-observer variability treatment planning , relative GTV , amongst radiation oncologist .</brief_summary>
	<brief_title>To Evaluate Impact PET/CT Radiation Treatment Planning Relation Changes GTV Stage 3 NSCLC</brief_title>
	<detailed_description>Primary objective study : 1.To determine impact PET/CT fusion gross tumor volume ( GTV ) primary ( GTVP ) nodal ( GTVN ) disease patient compare GTV contour use two separate data set . ( A ) GTVP CT+ GTVN CT+ ( B ) GTVP PET+ve GTVN PET +ve GTV measure record cubic centimeter volume . Secondary Endpoints : 1.Normal tissue toxicity:3D conformal Computerized radiation plan generate data set GTVP GTVN A B .Dose Volume Histogram ( DVH ) determine compare follow normal tissue toxicity parameter . I. V 20 Both lung ( Combined total lung volume include PTV ) : Volume lung receive ≥ 20 G , include plan target volume . II . Mean lung dose : Mean radiation dose receive lung give radiation plan , calculate planning computer . III . V 55 Esophagus : Volume esophagus receiving≥ 55Gy . IV . Mean esophageal dose : Mean radiation dose receive whole esophagus give radiation plan , calculate planning computer V. Spinal cord dose : Maximum dose receive spinal cord give radiation plan . V1.. V40 Whole heart : Volume heart receive ≥ 40Gy 2A Inter observer variation : This determine data set GTV A B delineate 4 radiation oncologist blind , first 20 patient . The resident involve project responsible co-ordinate part project . GTV measure record cubic centimeter volume . 2B Intra observer variation : This determine data set GTV A B delineate radiation oncologist ( treat physician ) two different occasion , first 20 patient . Minimum time interval two contour one month .The resident involve project responsible co-ordinate part project . GTV measure record cubic centimeter volume .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Patients must eligible Oncology FDG PET Winnipeg PET Program/Edmonton Cross Cancer Institute Extended Phase III Clinical Trial Protocol 001 , addition ; Pathologically prove NSCLC Clinical stage III A ( inoperable ) stage IIIB intent pursue radical curative RT/chemo , stag conventional imaging outline standard work section . ECOG Performance status 02 Age ≥ 18 year FEV1 ≥ 1.0 L No prior concurrent malignancy except nonmelanomatous skin cancer unless diseasefree one year non primary bronchogenic cancer two year primary bronchogencic cancer ; No prior RT thorax . Must able start RT within 4 week PET/CT simulation Participants may treat radical radiation without concurrent chemotherapy , adjuvant chemotherapy neoadjuvant therapy . As per Oncology FDG PET Winnipeg PET Program/Edmonton Cross Cancer Institute Extended Phase III Clinical Trial Protocol 001 specifically : Unable/unwilling give informed consent . Uncontrolled hyperglycemia ( Blood sugar &gt; 12 mmol/L ) Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>PET/CT</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Lung Cancer</keyword>
</DOC>